Medical system and fluid circulation system

The medical system addresses the challenge of efficiently delivering fluid to the brain while stabilizing intracranial pressure by alternating fluid injection and drainage, ensuring effective treatment without nerve tissue damage.

JP2024180194APending Publication Date: 2024-12-26TERUMO KK
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2023099692
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-06-16
Publication Date
2024-12-26

AI Technical Summary

Technical Problem

Existing medical systems face challenges in efficiently delivering fluid to the treatment area of the brain while maintaining intracranial pressure within a certain range, as fluctuations in pressure can cause brain damage due to local steady flows and the risk of nerve tissue damage during catheter insertion.

Method used

A medical system that alternately injects fluid and drains cerebrospinal fluid from the body cavity, with control units managing periods of simultaneous injection and drainage to prevent local steady flows and maintain fluid balance, using a closed system with integrated syringe pumps to stabilize fluid volume.

Benefits of technology

The system efficiently delivers fluid to the brain treatment area while stabilizing intracranial pressure, preventing nerve tissue damage and maintaining cerebrospinal fluid levels, thus reducing the risk of brain damage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024180194000001_ABST
    Figure 2024180194000001_ABST
Patent Text Reader

Abstract

To provide a medical system and a fluid circulation system capable of efficiently delivering a fluid to a treatment region of the brain while suppressing fluctuation of an intracranial pressure.SOLUTION: The medical system comprises a control unit which executes control of: setting a first period 211 in which a cerebrospinal fluid is discharged from the inside of a body cavity while a fluid is infused into the body cavity and a second period 212 in which the fluid is not infused into the body cavity and the cerebrospinal fluid is not discharged from the inside of the body cavity; and repeating the first period 211 and the second period 212 alternately.SELECTED DRAWING: Figure 8
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a medical system and a fluid circulation system used in the treatment of brain diseases. [Background technology]

[0002] When a brain disease such as cerebral infarction occurs, the blood flow that supplies oxygen to brain cells is blocked, which may cause damage to the brain cells. Therefore, when a cerebral infarction occurs, early reperfusion of blood flow is necessary. As one of the treatments for cerebral infarction, it has been proposed to inject a highly oxygenated solution such as oxygenated cerebrospinal fluid into the body cavity where the cerebrospinal fluid exists, thereby directly supplying oxygen to oxygen-deficient brain cells.

[0003] Patent Document 1 discloses a catheter system capable of injecting liquid into and suctioning liquid from a living body using one lumen. The catheter system described in Patent Document 1 includes a catheter, an injection drive unit that supplies fluid to an injection port through a lumen of a tube body, a suction drive unit that suctions fluid from a suction port through a lumen of the tube body, a detection unit that detects the state of intracranial pressure, and a control unit that controls the injection drive unit and the suction drive unit. The suction port of the catheter is in a closed state when the injection port of the catheter is in an open state. The injection port of the catheter is in a closed state when the suction port of the catheter is in an open state. The control unit alternately operates the injection drive unit and the suction drive unit so that the state of intracranial pressure detected by the detection unit is within a certain range.

[0004] Here, when a liquid such as a highly oxygenated solution is injected into a body cavity for the purpose of treating a brain disease, it is necessary to maintain the intracranial pressure within a certain range. The normal range of intracranial pressure is about 5 mmHg or more and 15 mmHg or less. Fluctuations in pressure from inside the skull to inside the spinal cavity may cause brain damage. For example, if the intracranial pressure rises to 20 mmHg or more, intracranial hypertension (i.e., various symptoms caused by stress on brain tissue) may occur. On the other hand, if the intracranial pressure falls to 5 mmHg or less, low cerebrospinal fluid pressure syndrome (i.e., various symptoms caused by the inability to maintain the position of brain tissue) may occur.

[0005] The body cavities in which cerebrospinal fluid exists (e.g., the subarachnoid space and the ventricles) are almost closed spaces. Therefore, in order to maintain the intracranial pressure within a certain range, it is necessary to maintain the amount of cerebrospinal fluid in the body cavities within a certain range. In order to maintain the amount of cerebrospinal fluid in the body cavities within a certain range, it is necessary to quickly drain the same amount of cerebrospinal fluid as the amount of fluid injected into the body cavity.

[0006] However, for example, when a liquid is injected into a body cavity by circulating the liquid with a pump through an injection catheter and a drainage catheter inserted into the subarachnoid space near the lumbar spine, depending on the timing of injection and drainage, a flow of the liquid injected into the body cavity from the injection catheter's inlet toward the drainage catheter's outlet (i.e., a local steady flow) is formed. This causes a problem that the flow of the liquid from the injection catheter's inlet toward the treatment area of ​​the brain becomes small, and the liquid cannot be efficiently delivered to the treatment area of ​​the brain.

[0007] To solve this problem, it is conceivable to place the inlet of the injection catheter near the brain and the outlet of the drainage catheter near the lumbar vertebrae, thereby providing a sufficient distance between the inlet and the outlet and minimizing the effect of the local steady flow. However, when attempting to insert a catheter close to the brain, the catheter must be inserted over a long distance into the curved subarachnoid space, which is surrounded by nerve tissue such as the spinal cord. Inserting such a catheter deep into the subarachnoid space carries the risk of damaging the nerve tissue, so it is desirable to make the insertion length of the catheter as short as possible.

[0008] In addition, it is desirable that the liquid circulation circuit is a closed system to prevent infection. However, if the liquid circulation circuit is a closed system, the total volume of the liquid may increase compared to the volume at the beginning of treatment due to bubbles generated in the circulation circuit by the cavitation phenomenon, or the total volume of the liquid may decrease compared to the volume at the beginning of treatment due to water evaporation loss during the process of oxygenating the cerebrospinal fluid. If the total volume of the liquid increases or decreases in a closed circulation circuit, it may not be possible to maintain the intracranial pressure within a certain range. [Prior art documents] [Patent documents]

[0009] [Patent Document 1] International Publication No. 2021 / 192539 Summary of the Invention [Problem to be solved by the invention]

[0010] The present invention has been made in consideration of the above circumstances, and aims to provide a medical system and a fluid circulation system that can efficiently deliver fluid to a treatment area of ​​the brain while suppressing fluctuations in intracranial pressure. [Means for solving the problem]

[0011] The present invention is (1) a medical system for injecting a liquid into a body cavity in which cerebrospinal fluid of a subject is present and discharging the cerebrospinal fluid present in the body cavity from the body cavity, the medical system being characterized in that it has a control unit that sets a first period in which the liquid is injected into the body cavity while the cerebrospinal fluid is discharged from the body cavity, and a second period in which the liquid is not injected into the body cavity and the cerebrospinal fluid is not discharged from the body cavity, and executes control to alternately repeat the first period and the second period.

[0012] According to the medical system of (1) above, the control unit executes control in the first period to inject liquid into the body cavity in which the cerebrospinal fluid of the subject is present while discharging the cerebrospinal fluid from the body cavity. Also, the control unit executes control in the second period to not inject liquid into the body cavity and not discharge the cerebrospinal fluid from the body cavity. Then, the control unit executes control to alternately repeat the first period and the second period. This causes the injection of liquid and the discharge of cerebrospinal fluid to be repeated simultaneously and intermittently. Therefore, a period occurs in which the liquid injected into the body cavity from the inlet does not flow locally toward the outlet, and diffusion due to the concentration difference of oxygen and the like contained in the liquid progresses during the period in which the local steady flow does not exist. This allows the liquid to be efficiently delivered to the treatment area of ​​the brain. Also, since the injection of liquid and the discharge of cerebrospinal fluid are executed simultaneously, the amount of cerebrospinal fluid in the body cavity can be kept within a certain range. This allows the fluctuation of intracranial pressure to be suppressed.

[0013] (2) In the medical system of (1) above, it is preferable that the amount of the liquid injected during the first period is substantially the same as the amount of cerebrospinal fluid discharged during the first period. According to the medical system of (2) above, since the amount of fluid injected is substantially the same as the amount of cerebrospinal fluid discharged, the amount of cerebrospinal fluid in the body cavity can be more reliably kept within a constant range, thereby more reliably suppressing fluctuations in intracranial pressure.

[0014] (3) In the medical system of (1) or (2) above, it is preferable that the period from the start of the first period to the end of the second period is substantially constant. According to the medical system of (3) above, the movement of the liquid and the diffusion due to the difference in the concentration of oxygen and the like contained in the liquid proceed stably. This allows the liquid to be efficiently delivered to the treatment area of ​​the brain. Also, the amount of cerebrospinal fluid in the body cavity can be stably maintained within a certain range. This makes it possible to suppress fluctuations in intracranial pressure.

[0015] (4) In any one of the medical systems (1) to (3) above, the second period of time is preferably 15 seconds or longer. The medical system described in (4) above allows sufficient time for the movement of the liquid and diffusion due to differences in the concentration of oxygen and other substances contained in the liquid to proceed, and also stops the local steady flow that remains due to inertia, allowing the liquid to be efficiently delivered to the treatment area of ​​the brain.

[0016] (5) In any of the medical systems (1) to (4) above, the control is a first control, and the control unit is further capable of executing a second control in which the control unit sets a third period in which the liquid is injected into the body cavity and the cerebrospinal fluid is not discharged from the body cavity, and a fourth period in which the liquid is not injected into the body cavity and the cerebrospinal fluid is discharged from the body cavity, and alternates between the third period and the fourth period, and sets the injection amount of the liquid in the third period to be substantially the same as the discharge amount of the cerebrospinal fluid in the fourth period, and it is preferable to select and execute either the first control or the second control.

[0017] According to the medical system of (5) above, the control unit injects liquid into the body cavity and does not discharge cerebrospinal fluid from the body cavity in the third period. Moreover, the control unit does not inject liquid into the body cavity and discharges cerebrospinal fluid from the body cavity in the fourth period. Then, the control unit alternates between the third period and the fourth period, and makes the amount of liquid injected substantially the same as the amount of cerebrospinal fluid discharged. As a result, the injection of liquid and the discharge of cerebrospinal fluid are alternately repeated in the second control in the same amount, as long as the allowable fluctuation range of the intracranial pressure is not exceeded. Therefore, since the injection period of the liquid and the discharge period of the cerebrospinal fluid are performed with a time lag, the two periods do not overlap, and the occurrence of a local steady flow of the liquid injected from the injection port into the body cavity toward the discharge port can be suppressed. Furthermore, the control unit can select and execute either the control of (1) above (i.e., the first control) or the control of (2) above (i.e., the second control). This allows the medical system described above in (5) to flexibly respond to various conditions, such as the subject's intracranial pressure and the amount of cerebrospinal fluid, and efficiently deliver fluid to the treatment area of ​​the brain.

[0018] (6) The medical system of (1) above further comprises an injection catheter for injecting the liquid into the body cavity and a drainage catheter for draining the cerebrospinal fluid from the body cavity, and it is preferable that the distance between the tip of the injection catheter and the tip of the drainage catheter is 30 centimeters or less when execution of the control begins. According to the medical system of (6) above, since the injection of liquid and the discharge of cerebrospinal fluid are repeated simultaneously and intermittently, even if the distance between the tip of the injection catheter and the tip of the discharge catheter is 30 centimeters or less at the start of control execution, a period can be secured during which the liquid injected from the inlet of the injection catheter into the body cavity does not flow locally toward the outlet of the discharge catheter. This allows diffusion due to concentration differences in oxygen and other substances contained in the liquid to proceed during the period during which the local steady flow does not occur. This allows the liquid to be efficiently delivered to the treatment area of ​​the brain without inserting the injection catheter deeply into the living body.

[0019] The present invention relates to (7) a liquid circulation system for circulating a liquid by injecting the liquid into a body and discharging the liquid outside the body, comprising an injection catheter for injecting the liquid into the body, a drainage catheter for discharging the liquid from inside the body to outside the body, a system circuit unit connected to the injection catheter and the drainage catheter, an injection fluid storage unit for storing the liquid supplied from the system circuit unit and injected into the body, a drainage fluid storage unit for storing the liquid drained from inside the body to outside the body, and a drainage fluid storage unit connected to the injection fluid storage unit and the injection catheter, for supplying the liquid to the injection fluid storage unit and supplying the liquid stored in the injection fluid storage unit to the injection catheter. a first fluid delivery section connected to the drainage liquid storage section and the drain catheter and configured to supply the liquid to the drainage liquid storage section and to supply the liquid stored in the drainage liquid storage section to the system circuit section; a first fluid delivery section provided downstream of the injection fluid storage section and configured to switch between a fluid flow path connecting the system circuit section to the injection fluid storage section and a fluid flow path connecting the injection fluid storage section to the injection catheter; and a second fluid flow path switching section provided upstream of the drainage liquid storage section and configured to switch between a fluid flow path connecting the drainage catheter to the drainage liquid storage section and a fluid flow path connecting the drainage liquid storage section to the system circuit section.

[0020] According to the liquid circulation system of (7) above, the circuit for circulating the liquid is divided into a circuit including the injection catheter and the discharge catheter (i.e., the biological circuit section) and a system circuit section connected to the injection catheter and the discharge catheter. In addition, a first liquid delivery section that supplies the liquid to the injection catheter and a second liquid delivery section that supplies the liquid to the system circuit section function as a liquid delivery section shared by the biological circuit section and the system circuit section. In addition, the first flow path switching section and the second flow path switching section can switch the flow path through which the liquid flows. With this configuration of the liquid circulation system, the system circuit section can respond to an increase in the total volume of the liquid caused by the cavitation phenomenon and a decrease in the total volume of the liquid caused by evaporation while maintaining the condition on the biological side, and the increase or decrease in the total volume of the liquid can be suppressed. This makes it possible to suppress fluctuations in intracranial pressure.

[0021] (8) In the liquid circulation system of (7) above, it is preferable that the first liquid delivery unit and the second liquid delivery unit operate in conjunction with each other so that the volume of the liquid injected into the body is always equal to the volume of the liquid discharged from the body. According to the above-mentioned (8) liquid circulation system, the first liquid delivery unit and the second liquid delivery unit work in conjunction with each other and function as one liquid delivery unit shared by the biological circuit unit and the system circuit unit. The volume of liquid injected into the body is always equal to the volume of liquid discharged from the body. Therefore, the amount of cerebrospinal fluid in the body can be more reliably kept within a constant range. This makes it possible to more reliably suppress fluctuations in intracranial pressure.

[0022] (9) The liquid circulation system of (7) above further includes a piston drive unit, the injection liquid storage unit being a first syringe that stores the liquid, the discharge liquid storage unit being a second syringe that stores the liquid, the first liquid delivery unit being a first piston that can slide and move back and forth within the first syringe, and the second liquid delivery unit being a second piston that can slide and move back and forth within the second syringe, and it is preferable that the first piston and the second piston are connected to each other and move back and forth by the piston drive unit while connected to each other.

[0023] According to the liquid circulation system of (9) above, a first piston that can slide and reciprocate in a first syringe and a second piston that can slide and reciprocate in a second syringe are reciprocated by a piston drive unit while being connected to each other. As a result, the first liquid delivery unit and the second liquid delivery unit function as a single shared liquid delivery unit integrated in the biological circuit unit and the system circuit unit. Therefore, the volume of liquid injected into the body is equal to the volume of liquid discharged outside the body. Therefore, the amount of cerebrospinal fluid in the body can be kept within a constant range. This makes it possible to suppress fluctuations in intracranial pressure.

[0024] (10) In the liquid circulation system of (9) above, it is preferable that the first syringe and the second syringe are formed to have the same shape and capacity, so that the volume of the liquid injected into the body is always equal to the volume of the liquid discharged from the body. According to the above-mentioned (10) liquid circulation system, such a fixed-displacement pump does not fluctuate the amount of liquid injected and discharged in one cycle, and can reliably make the injected amount and discharged amount the same compared to a variable-displacement pump. Therefore, the amount of cerebrospinal fluid in the body can be more reliably kept within a constant range. This makes it possible to more reliably suppress fluctuations in intracranial pressure.

[0025] (11) In the liquid circulation system of (7) above, it is preferable that the system circuit section has an oxygen supply device that supplies oxygen to the liquid discharged outside the body. The liquid circulation system described above in (11) can efficiently deliver highly oxygenated solution to the treatment area of ​​the brain while suppressing fluctuations in intracranial pressure. Effect of the Invention

[0026] According to the present invention, it is possible to provide a medical system and a fluid circulation system that can efficiently deliver fluid to a treatment area of ​​the brain while suppressing fluctuations in intracranial pressure. [Brief description of the drawings]

[0027] [Figure 1] 1 is a schematic diagram illustrating an overview of a medical system according to an embodiment of the present invention. [Diagram 2] 1 is a plan view showing the vicinity of an injection port of the injection catheter of the present embodiment. FIG. [Diagram 3] FIG. 2 is a plan view showing the vicinity of the outlet of the drainage catheter of the present embodiment. [Figure 4] 4 is a cross-sectional view taken along a cutting plane BB shown in FIG. [Diagram 5] FIG. 2 is a schematic diagram illustrating the flow of liquid occurring within a body cavity immediately after the start of liquid circulation. [Figure 6] FIG. 2 is a schematic diagram illustrating the flow of liquid occurring within a body cavity during liquid circulation. [Figure 7] 1 is a schematic diagram illustrating the flow of liquid occurring within a body cavity after liquid circulation has stopped. FIG. [Figure 8] 11 is a graph showing the relationship between the injection amount, the discharge amount, and the amount of fluid in the body cavity under the control of this embodiment. [Figure 9] 5A to 5C are schematic diagrams illustrating the flow of liquid occurring within a body cavity under the control of this embodiment. [Figure 10] 13 is a graph showing the relationship between the injection amount, the discharge amount, and the amount of fluid in the body cavity under another control of this embodiment. [Figure 11] 13 is a schematic diagram illustrating the flow of liquid occurring within a body cavity during injection under another control according to this embodiment. FIG. [Figure 12] 13A to 13C are schematic diagrams illustrating the flow of liquid occurring in a body cavity while another control in this embodiment is stopped. [Figure 13]13 is a schematic diagram illustrating the flow of liquid occurring in a body cavity during discharge under another control in this embodiment. FIG. [Figure 14] FIG. 1 is a schematic diagram for explaining an outline of an experiment carried out by the present inventor. [Figure 15] 1 is a table illustrating an example of the results of an experiment conducted by the present inventor. [Figure 16] 1 is a photograph showing an experiment carried out by the present inventor. [Figure 17] 1 is a schematic diagram illustrating an overview of a liquid circulation system according to an embodiment of the present invention. [Figure 18] 5A to 5C are schematic diagrams illustrating the operation of the liquid circulation system according to the present embodiment. [Figure 19] 5A to 5C are schematic diagrams illustrating the operation of the liquid circulation system according to the present embodiment. [Figure 20] 7A to 7C are schematic diagrams illustrating another operation of the liquid circulation system according to the embodiment. [Figure 21] 7A to 7C are schematic diagrams illustrating another operation of the liquid circulation system according to the present embodiment. [Figure 22] 7A to 7C are schematic diagrams illustrating another operation of the liquid circulation system according to the present embodiment. [Figure 23] 7A to 7C are schematic diagrams illustrating another operation of the liquid circulation system according to the embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0028] Hereinafter, an embodiment of the present invention will be described with reference to the drawings. The embodiments described below are preferred specific examples of the present invention, and therefore various technically preferable limitations are applied to them, but the scope of the present invention is not limited to these aspects unless otherwise specified in the following description to the effect that the present invention is limited to them. In addition, in each drawing, similar components are given the same reference numerals, and detailed descriptions thereof are omitted as appropriate.

[0029] FIG. 1 is a schematic diagram illustrating an overview of a medical system according to an embodiment of the present invention. The medical system 2 according to the present embodiment injects a liquid into a body cavity in which a subject's cerebrospinal fluid (CSF) exists, and drains the liquid present in the body cavity from the body cavity. Cerebrospinal fluid exists mainly in the subarachnoid space and the ventricles. That is, the body cavities in which cerebrospinal fluid exists include the subarachnoid space and the ventricles.

[0030] As shown in FIG. 1, the medical system 2 includes a control unit 21, a pump 22, and a medical device 5. The control unit 21 is connected to the pump 22 and transmits a control signal to the pump 22 to control the operation of the pump 22. The pump 22 operates based on the control signal transmitted from the control unit 21, and as shown by an arrow A1 in FIG. 1, the pump 22 aspirates and discharges cerebrospinal fluid from the subject's body cavity via the medical device 5. The cerebrospinal fluid discharged outside the body cavity by the pump 22 is generated into a liquid (i.e., a highly oxygenated solution) having an oxygen concentration higher than that of normal cerebrospinal fluid, for example, by an oxygenation mechanism (not shown). Then, as shown by an arrow A2 in FIG. 1, the pump 22 injects the liquid into the body cavity via the medical device 5.

[0031] The liquid injected into the body cavity is not limited to a highly oxygenated solution. For example, the liquid injected into the body cavity may be a liquid containing a drug obtained by adding a drug to cerebrospinal fluid during extracorporeal circulation, or may be cerebrospinal fluid filtered with a filter to remove undesirable substances during extracorporeal circulation. In addition, the liquid injected into the body cavity may be cerebrospinal fluid that has been subjected to some treatment, such as irradiation with energy or heating, and then returned to the body cavity. In the following description, for convenience of explanation, an example in which the liquid injected into the body cavity is a highly oxygenated solution may be given. In addition, lactated Ringer's solution can be used as a substitute for cerebrospinal fluid in the early stages of treatment. In this embodiment, cerebrospinal fluid, artificial cerebrospinal fluid such as lactated Ringer's solution, and a mixture of cerebrospinal fluid and lactated Ringer's solution may be collectively referred to as liquid.

[0032] As shown in FIG. 1, the medical device 5 has a drainage catheter 51 and an injection catheter 52, and is inserted into the subarachnoid space from the vicinity of the lumbar vertebrae in a lateral position. The tip position of the injection catheter 52 is desirably between the vicinity of the sixth thoracic vertebrae from the top, called T6, and the position of the first lumbar vertebrae from the top, called L1, in consideration of safety during insertion. For example, as shown by an arrow A11 in FIG. 1, the drainage catheter 51 sucks cerebrospinal fluid present in the body cavity from an outlet 511 and discharges it outside the body cavity. For example, as shown by an arrow A13 in FIG. 1, the injection catheter 52 injects liquid from an inlet 521 into a body cavity such as the subarachnoid space where cerebrospinal fluid is present.

[0033] FIG. 2 is a plan view showing the vicinity of the injection port of the injection catheter of this embodiment. FIG. 3 is a plan view showing the vicinity of the outlet of the drainage catheter of this embodiment. FIG. 4 is a cross-sectional view taken along the cutting plane BB shown in FIG.

[0034] As shown in FIG. 3, the tip of the drainage catheter 51 is opened as a drainage port 511 and is placed in the subarachnoid space near the lumbar vertebrae. For example, as shown by arrows A11 and A12 in FIG. 3, the drainage catheter 51 is inserted into the subarachnoid space of the subject, and cerebrospinal fluid present in the subarachnoid space near the lumbar vertebrae is sucked through the drainage port 511 into the space 53 (see FIG. 4) between the inner cavity 513 of the drainage catheter 51 and the outer surface of the injection catheter 52. As described above with reference to FIG. 1, the force for sucking the cerebrospinal fluid is provided by the pump 22. Then, as shown by arrow A1 in FIG. 1, the drainage catheter 51 discharges the cerebrospinal fluid through the space 53 to the outside of the subject's body cavity.

[0035] The outer diameter of the injection catheter 52 is smaller than the inner diameter of the drainage catheter 51. The injection catheter 52 is capable of being placed in the lumen 513 of the drainage catheter 51. The injection catheter 52 is not coupled to the drainage catheter 51 and is capable of moving in the lumen 513 of the drainage catheter 51 along the longitudinal direction D1 (see FIG. 3 ) of the drainage catheter 51. Since the tip of the drainage catheter 51 is open as the drainage port 511, as shown in FIG. 3 , the tip of the injection catheter 52 is capable of passing through the drainage port 511 of the drainage catheter 51.

[0036] This allows the tip of the injection catheter 52 to be exposed from the outlet 511 of the drainage catheter 51 in the longitudinal direction D1 of the drainage catheter 51. The distance in the longitudinal direction D1 between the tip of the drainage catheter 51 and the tip of the injection catheter 52 exposed from the outlet 511 of the drainage catheter 51 can be adjusted to a predetermined distance. In the present specification, the "predetermined distance" is, for example, 0 cm or more and 30 cm or less. This makes it possible to avoid risks that occur when inserting the catheter deeply into the subarachnoid space of a patient.

[0037] As shown in Fig. 2, the tip of the injection catheter 52 is opened as an injection port 521, and is disposed in the subarachnoid space through the outlet port 511 of the outlet catheter 51. For example, as shown by the arrow A13 in Fig. 2, the injection catheter 52 is inserted into the subarachnoid space of the patient, and liquid is injected into the cerebrospinal fluid present in the subarachnoid space through the inner cavity 523 (see Fig. 4) of the injection catheter 52. Note that, as described above with reference to Fig. 1, the force for injecting the liquid into the cerebrospinal fluid is provided by the pump 22.

[0038] In a cross section BB (see FIG. 4) perpendicular to the longitudinal direction D1, the cross-sectional area of ​​the space 53 between the outside of the injection catheter 52 and the inside of the drainage catheter 51 is set within a range of a predetermined ratio to the cross-sectional area of ​​the lumen 523 of the injection catheter 52 in order to keep the intracranial pressure (ICP) constant within a certain range. Since it is undesirable for the intracranial pressure to be higher or lower than the limit range, it is preferable to set the ratio of the cross-sectional area of ​​the space 53 to the cross-sectional area of ​​the lumen 523 within a certain range centered on 1. The "predetermined ratio" in this specification is preferably, for example, 0.5 times or more and 2 times or less. However, the "predetermined ratio" in this specification is not limited to 0.5 times or more and 2 times or less.

[0039] Next, the flow of liquid that occurs within a body cavity during liquid circulation will be described with reference to the drawings. FIG. 5 is a schematic diagram illustrating the flow of liquid that occurs within a body cavity immediately after the start of liquid circulation. FIG. 6 is a schematic diagram illustrating the flow of liquid occurring within a body cavity during liquid circulation. FIG. 7 is a schematic diagram illustrating the flow of liquid that occurs within a body cavity after the liquid circulation has stopped.

[0040] As shown in Fig. 5, immediately after the start of liquid circulation, liquid 91 injected into the body cavity from inlet 521 of infusion catheter 52 flows forward (i.e., in the direction in which the brain is located) as shown by arrow A13 in Fig. 5, for example, until the suction flow when cerebrospinal fluid is discharged from outlet 511 of drainage catheter 51 reaches inlet 521 as described later in Fig. 6. The flow rate of liquid 91 flowing forward is slightly higher than in the case described later in Fig. 6. Also, in the short time immediately after the start of liquid circulation, there is almost no diffusion due to concentration differences of oxygen, medicine, etc. contained in the liquid (hereinafter referred to as "oxygen, etc." for convenience of explanation).

[0041] 6, during liquid circulation, i.e., during continuous circulation of the liquid, the suction flow when the cerebrospinal fluid is discharged from the discharge port 511 of the discharge catheter 51 reaches and affects the inlet 521 of the injection catheter 52. Then, the flow from the inlet 521 of the injection catheter 52 toward the discharge port 511 of the discharge catheter 51 becomes steady. That is, as shown by arrows A14 and A15 in FIG. 6, for example, a local steady flow is generated in which the liquid 91 injected from the inlet 521 of the injection catheter 52 into the body cavity toward the discharge port 511 of the discharge catheter 51. As a result, the liquid 91 injected from the inlet 521 of the injection catheter 52 into the body cavity hardly flows forward (i.e., in the direction toward which the brain is present).

[0042] Also, due to the effect of the local steady flow, the diffusion of oxygen and the like contained in the liquid 91 toward the brain side slows down compared to immediately after the start of liquid circulation. Due to the effect of the local steady flow, the liquid 91 that has diffused toward the lumbar side due to the difference in concentration of oxygen and the like contained in the liquid 91 is discharged outside the body cavity from the discharge port 511 of the discharge catheter 51.

[0043] As shown in Fig. 7, after the liquid circulation stops, the local steady flow that occurred during the liquid circulation disappears. Therefore, for example, as shown by arrows A16 and A17 in Fig. 7, diffusion of oxygen and the like contained in the liquid 91 occurs toward the brain side and the lumbar side.

[0044] 6, when continuous circulation of the liquid is performed, a local steady flow of the liquid 91 injected into the body cavity from the inlet 521 of the injection catheter 52 toward the outlet 511 of the drainage catheter 51 occurs. This results in a small flow of the liquid 91 from the inlet 521 of the injection catheter 52 toward the treatment region of the brain, making it difficult to efficiently deliver the liquid 91 to the treatment region of the brain.

[0045] Therefore, the control unit 21 of the medical system 2 according to this embodiment sets a first period during which the cerebrospinal fluid is discharged from the body cavity while the liquid 91 is injected into the body cavity, and a second period during which the liquid 91 is not injected into the body cavity and the cerebrospinal fluid is not discharged from the body cavity, and executes control to alternately repeat the first period and the second period. Details of the control of the medical system 2 according to this embodiment will be described below with reference to the drawings.

[0046] FIG. 8 is a graph showing the relationship between the injection amount, the discharge amount, and the amount of fluid in the body cavity under the control of this embodiment. FIG. 9 is a schematic diagram for explaining the flow of liquid occurring within a body cavity under the control of this embodiment.

[0047] The horizontal axis of the graph shown in FIG. 8 represents time. The vertical axis of the graph shown in FIG. 8 represents the change in the amount of fluid. Specifically, the "injection amount" shown in FIG. 8 represents the cumulative amount of fluid 91 injected into the body cavity from the start of control execution. The "discharge amount" shown in FIG. 8 represents the cumulative amount of cerebrospinal fluid discharged outside the body cavity from the start of control execution. The "amount of fluid in the body cavity" shown in FIG. 8 represents the amount of change in the cerebrospinal fluid present in the body cavity at the start of control execution.

[0048] 8, the control unit 21 of this embodiment sets a first period 211 in which cerebrospinal fluid is discharged from the body cavity while injecting the liquid 91 into the body cavity, and a second period 212 in which the liquid 91 is not injected into the body cavity and the cerebrospinal fluid is not discharged from the body cavity. That is, in the first period 211, the injection of the liquid 91 into the body cavity and the discharge of the liquid 91 from the body cavity are simultaneously performed. On the other hand, in the second period 212, the injection of the liquid 91 into the body cavity and the discharge of the liquid 91 from the body cavity are simultaneously stopped.

[0049] Then, as shown in Fig. 8, the control unit 21 alternately repeats the first period 211 and the second period 212. This causes the injection of the liquid 91 and the discharge of the cerebrospinal fluid to be simultaneously and intermittently repeated. The control relating to the graph shown in Fig. 8 is an example of the "first control" of the present invention.

[0050] In the first control of the medical system 2 according to this embodiment, the state immediately after the start of the liquid circulation described above with reference to FIG. 5 and the state after the stop of the liquid circulation described above with reference to FIG. 7 are periodically present. Therefore, a period occurs in which the local steady flow of the liquid 91 injected into the body cavity from the inlet 521 of the injection catheter 52 toward the outlet 511 of the outlet catheter 51 does not occur. As a result, as shown in FIG. 9, the amount of the liquid 91 supplied to the brain side from the inlet 521 of the injection catheter 52 increases according to the period. Also, as shown by the arrows A18, A19, and A20 in FIG. 9, diffusion due to the concentration difference of oxygen and the like contained in the liquid 91 progresses during the period in which there is no local steady flow. This allows the liquid 91 to be efficiently delivered to the treatment area of ​​the brain.

[0051] 8, the injection of the liquid 91 and the drainage of the cerebrospinal fluid are performed simultaneously, so that the amount of liquid present in the body cavity at the start of the control is kept within a certain range. This makes it possible to suppress fluctuations in intracranial pressure.

[0052] 8, the amount of liquid 91 injected during the first period 211 is substantially the same as the amount of cerebrospinal fluid discharged during the first period 211. This means that the amount of liquid present in the body cavity at the start of control execution hardly changes over time and is more reliably maintained within a constant range. This makes it possible to more reliably suppress fluctuations in intracranial pressure.

[0053] The period from the start of the first period 211 to the end of the second period 212 is substantially constant during the execution of the control. Therefore, the movement of the liquid 91 and the diffusion due to the difference in concentration of oxygen and the like contained in the liquid 91 proceed stably. This allows the therapeutic substance (oxygen and the like) to be efficiently delivered to the treatment area of ​​the brain. In addition, the amount of liquid present in the body cavity at the start of the execution of the control is stably maintained within a certain range. This allows the fluctuation of intracranial pressure to be suppressed. The duration of the second period 212 is preferably 15 seconds or more. This ensures sufficient time for the movement of the liquid 91 and the diffusion due to the difference in concentration of oxygen and the like contained in the liquid 91 to proceed, and also stops the local steady flow remaining due to inertia. This allows the liquid 91 to be efficiently delivered to the treatment area of ​​the brain.

[0054] Next, other controls of the medical system according to this embodiment will be described with reference to the drawings. FIG. 10 is a graph showing the relationship between the injection amount, the discharge amount, and the amount of fluid in the body cavity under another control of this embodiment. FIG. 11 is a schematic diagram illustrating the flow of liquid occurring within a body cavity during injection under another control according to this embodiment. FIG. 12 is a schematic diagram illustrating a flow of liquid occurring within a body cavity while another control in this embodiment is stopped. FIG. 13 is a schematic diagram for explaining the flow of liquid occurring in the body cavity during discharge under another control in this embodiment.

[0055] The horizontal and vertical axes of the graph shown in FIG. 10, as well as the "injection amount," "discharge amount," and "amount of fluid in the body cavity" shown in FIG. 10, are as described above with reference to FIG.

[0056] 10, in another control of this embodiment, the control unit 21 sets a third period 213 in which the liquid 91 is injected into the body cavity and the cerebrospinal fluid is not discharged from the body cavity, and a fourth period 214 in which the liquid 91 is not injected into the body cavity and the cerebrospinal fluid is discharged from the body cavity. That is, in the third period 213, only the injection of the liquid 91 into the body cavity is performed. On the other hand, in the fourth period 214, only the discharge of the liquid 91 from the body cavity is performed.

[0057] 10, the control unit 21 alternately repeats the third period 213 and the fourth period 214. The amount of injection of the liquid 91 in the third period 213 is substantially the same as the amount of discharge of the cerebrospinal fluid in the fourth period 214. As a result, the injection of the liquid 91 and the discharge of the cerebrospinal fluid are alternately repeated in the same amount as long as the allowable fluctuation range of the intracranial pressure is not exceeded. The control related to the graph shown in FIG. 10 is an example of the "second control" of the present invention.

[0058] In the second control of the medical system 2 according to this embodiment, the injection period of the liquid 91 and the discharge period of the cerebrospinal fluid are carried out with a time stagger, so that the two periods do not overlap, and the occurrence of a local steady flow of the liquid 91 injected into the body cavity from the injection port 521 of the injection catheter 52 toward the discharge port 511 of the discharge catheter 51 can be suppressed.

[0059] As shown in FIG. 11, in the third period 213, the liquid 91 injected into the body cavity from the inlet 521 of the injection catheter 52 flows toward the brain according to the injection direction and injection flow rate. Also, as shown by the arrow A21 in FIG. 11, for example, the liquid 91 and the cerebrospinal fluid are stirred by turbulence caused by resistance between the liquid 91 injected into the body cavity from the inlet 521 of the injection catheter 52 and the cerebrospinal fluid in the body cavity. Furthermore, as shown by the arrows A22 and A23 in FIG. 11, for example, diffusion due to the difference in concentration of oxygen and the like contained in the liquid 91 progresses. This allows oxygen and the like to be efficiently delivered to the treatment area of ​​the brain. Also, since the injection amount of the liquid 91 in the third period 213 is substantially the same as the discharge amount of the cerebrospinal fluid in the fourth period 214, the amount of the cerebrospinal fluid in the body cavity is kept within a certain range. This allows the fluctuation of the intracranial pressure to be suppressed.

[0060] 13, in the fourth period 214, the liquid 91 flows toward the outlet 511 of the discharge catheter 51 in an amount equal to the amount of liquid 91 injected into the body cavity from the inlet 521 of the injection catheter 52, and is sucked into the outlet 511 of the discharge catheter 51. Also, the liquid 91 injected into the body cavity from the inlet 521 of the injection catheter 52 is generally pulled back toward the outlet 511 of the discharge catheter 51, while the liquid 91, oxygen, etc., that spread in the injection direction remain in the body cavity, for example, as indicated by the arrow A27 in FIG.

[0061] As shown in FIG. 10, the control unit 21 further sets a second period 212 (see also FIG. 8) between the third period 213 and the fourth period 214 and between the fourth period 214 and the third period 213, during which the liquid 91 is not injected into the body cavity and the cerebrospinal fluid is not discharged from the body cavity. That is, as described above with reference to FIG. 8, during the second period 212, the injection of the liquid 91 into the body cavity and the discharge of the liquid 91 from the body cavity are stopped simultaneously. The control unit 21 repeats the third period 213, the second period 212, the fourth period 214, and the second period 212 in this order. During the second period, as shown by the arrows A24 and A25 in FIG. 12, for example, diffusion due to the difference in concentration of oxygen and the like contained in the liquid 91 progresses toward the brain side and the lumbar side according to the time of the second period 212 (i.e., the stop time).

[0062] Furthermore, the control unit 21 selects and executes either the first control described above with reference to Figures 8 to 9 or the second control described above with reference to Figures 10 to 13. This allows the medical system 2 according to this embodiment to flexibly respond to various conditions such as the intracranial pressure and the amount of cerebrospinal fluid of the subject, and efficiently delivers the liquid 91 to the treatment region of the brain.

[0063] Next, an example of an experiment carried out by the present inventor will be described with reference to the drawings. FIG. 14 is a schematic diagram for explaining an outline of an experiment carried out by the present inventor. FIG. 15 is a table illustrating an example of the results of an experiment carried out by the present inventor. FIG. 16 is a photograph showing an experiment carried out by the present inventor. Fig. 16(a) is a photograph showing the state at the start of the experiment. Fig. 16(b) is a photograph showing the state halfway through the experiment, i.e., when the colored water 911 has reached the middle position of the tube 55. Fig. 16(c) is a photograph showing the state when the colored water 911 has reached the goal position. For ease of explanation, the colored water 911 is shaded in the photographs of Figs. 16(b) and 16(c).

[0064] The inventors used a model simulating the spinal cord portion of the subarachnoid space as shown in Figs. 16(a) to 16(c), injected colored water 911 into tube 55 from injection port 521 of injection catheter 52, and compared the time required for colored water 911 to reach a position set as a goal after being injected into tube 55. In the models shown in Figs. 16(a) to 16(c), the inner cavity of tube 55 is a portion simulating the subarachnoid space. The inner cavity of tank 56 is a portion simulating the inside of the skull. The goal position is a position near the connection between tube 55 and tank 56, and a position immediately after colored water 911 that has passed through tube 55 flows into tank 56. The goal position is a portion simulating the cisterna magna.

[0065] 14, the distance in the longitudinal direction D1 (see FIG. 3) between the tip of the drainage catheter 51 (i.e., drain port 511) and the tip of the injection catheter 52 exposed from the drainage port 511 of the drainage catheter 51 (i.e., injection port 521) is 20 cm. Also, the distance in the longitudinal direction D1 between the injection port 521 of the injection catheter 52 and the goal position (i.e., the part simulating the cisterna magna) is 20 cm.

[0066] The injection and discharge methods in this experiment will be explained with reference to FIG. In the table shown in Fig. 15, "continuous circulation" is a method of continuously injecting and discharging colored water 911, and is a method as a comparative example. That is, as shown in the table shown in Fig. 15, in "continuous circulation", the control unit 21 sets a period during which the colored water 911 is continuously injected and discharged at a flow rate of 20 mL / min.

[0067] In the table shown in FIG. 15, "intermittent circulation" is a method of injection and discharge when the first control described above with reference to FIG. 8 to FIG. 9 is executed. That is, as shown in the table shown in FIG. 15, in "intermittent circulation", the control unit 21 sets a first period 211 in which the colored water 911 is injected into the tube 55 at a flow rate of 20 mL / min while discharging the colored water 911 from the tube 55 at a flow rate of 20 mL / min, and a second period 212 in which the colored water 911 is not injected into the tube 55 and is not discharged from the tube 55. The duration of the first period 211 is 15 seconds. In the first period 211, the colored water 911 is injected into the tube 55 at a flow rate of 20 mL / min for 15 seconds, so that the amount of the injected colored water 911 is 5 mL. Similarly, the amount discharged from the tube 55 is also 5 mL. The duration of the second period 212 is 45 seconds. Then, the control unit 21 alternately repeats the first period 211 and the second period 212.

[0068] In the table shown in FIG. 15, "equal volume infusion / discharge" is a method of injection and discharge when the second control described above with reference to FIGS. 10 to 13 is executed. That is, as shown in the table shown in FIG. 15, in "equal volume infusion / discharge", the control unit 21 sets a third period 213 in which the colored water 911 is injected into the tube 55 and is not discharged from the tube 55, and a fourth period 214 in which the colored water 911 is not injected into the tube 55 and is discharged from the tube 55. The duration of the third period 213 is 3 seconds. In the third period 213, the colored water 911 is injected into the tube 55 at a flow rate of 20 mL / min for 3 seconds, so that the amount of the colored water 911 injected is 1 mL. The duration of the fourth period 214 is 3 seconds. In the fourth period 214, the colored water 911 is discharged from the tube 55 at a flow rate of 20 mL / min for 3 seconds, so that the discharge amount of the colored water 911 is 1 mL. Then, the control unit 21 alternately repeats the third period 213 and the fourth period 214. Furthermore, in the "equal amount of infusion / discharge", the control unit 21 sets the second period 212, in which the colored water 911 is not injected into the tube 55 and the colored water 911 is not discharged from the tube 55, between the third period 213 and the fourth period 214 and between the fourth period 214 and the third period 213. The duration of the second period 212 is 12 seconds. Thus, in the "equal amount of infusion / discharge", the control unit 21 repeats the third period 213, the second period 212, the fourth period 214, and the second period 212 in this order.

[0069] An example of the results of this experiment is shown in the table of FIG. 15. That is, the colored water 911 was able to reach the goal position in all of the "continuous circulation", "intermittent circulation" and "equal volume inflow and outflow". The time required for the colored water 911 to reach the goal position after being injected into the tube 55 was 60 minutes in the "continuous circulation", 20 minutes in the "intermittent circulation", and 0.75 minutes in the "equal volume inflow and outflow". The amount of the colored water 911 injected from the injection into the tube 55 until it reaches the goal position was 1200 mL in the "continuous circulation", 100 mL in the "intermittent circulation", and 2 mL in the "equal volume inflow and outflow". The results of this experiment show that the "intermittent circulation" and "equal volume inflow and outflow" can deliver the colored water 911 to the goal position more efficiently than the "continuous circulation".

[0070] Next, the liquid circulation system according to the present embodiment will be described with reference to the drawings. In addition, in cases where the components of the liquid circulation system 3 are similar to the components of the medical system 2 described above with reference to Figs. 1 to 16, duplicated explanations will be omitted as appropriate, and the following explanation will focus on the differences.

[0071] FIG. 17 is a schematic diagram showing an overview of a liquid circulation system according to this embodiment. The liquid circulation system 3 according to this embodiment circulates a liquid by injecting the liquid into the body and discharging it out of the body. An example of the inside of the body is a body cavity in which the cerebrospinal fluid of the subject is present. In the explanation of the liquid circulation system 3 according to this embodiment, a case where the liquid injected into the body is a highly oxygenated solution is taken as an example.

[0072] As shown in FIG. 17, the liquid circulation system 3 includes a system circuit section 31, a biological circuit section 32, and a pump section 33.

[0073] The system circuit unit 31 is a part that generates a highly oxygenated solution, adjusts its temperature, and adjusts the total volume of the liquid in the circulation circuit, and includes the control unit 21, a reservoir 311, an oxygenation mechanism 312, and an oxygen supply source 313. The oxygenation mechanism 312 of this embodiment is an example of the "oxygenation device" of the present invention.

[0074] The system circuit section 31 further includes a first drive section 23, a second drive section 24, and a third drive section 25. The first drive section 23 of this embodiment is an example of a "piston drive section" of the present invention. The first drive section 23, the second drive section 24, and the third drive section 25 are each connected to the control section 21 and operate based on a control signal transmitted from the control section 21. The first drive section 23, the second drive section 24, and the third drive section 25 are, for example, actuators such as motors. The first drive section 23, the second drive section 24, and the third drive section 25 may be provided in the pump section 33.

[0075] The biological circuit section 32 is a section that injects liquid into the body and expels the liquid from the body, and has a drainage catheter 51 and an injection catheter 52. The drainage catheter 51 and the injection catheter 52 are connected to the system circuit section 31 via the pump section 33. The drainage catheter 51 and the injection catheter 52 are as described above with reference to Figures 1 to 16.

[0076] The pump section 33 functions as a liquid delivery section shared by the system circuit section 31 and the biological circuit section 32. The pump section 33 has a first syringe 331, a first piston 332, a first flow path switching section 333, a second syringe 334, a second piston 335, and a second flow path switching section 336. As described above, the pump section 33 may have the first drive section 23, the second drive section 24, and the third drive section 25.

[0077] The first syringe 331 of this embodiment is an example of the "injection liquid storage section" of the present invention. The first piston 332 of this embodiment is an example of the "first liquid delivery section" of the present invention. The second syringe 334 of this embodiment is an example of the "discharge liquid storage section" of the present invention. The second piston 335 of this embodiment is an example of the "second liquid delivery section" of the present invention.

[0078] As shown in FIG. 17, the oxygenation mechanism 312 is connected to the first flow path switching unit 333 through the first tube 41. The oxygenation mechanism 312 is also connected to the reservoir 311 through the seventh tube 47. The oxygenation mechanism 312 is also connected to the oxygen supply source 313 through the eighth tube 48. The oxygenation mechanism 312 mixes cerebrospinal fluid or artificial cerebrospinal fluid such as lactate Ringer's solution or a mixture thereof supplied from the reservoir 311 through the seventh tube 47 with oxygen supplied from the oxygen supply source 313 through the eighth tube to generate oxygenated cerebrospinal fluid. The oxygenation mechanism 312 also has a heat exchanger that adjusts the temperature of the oxygenated cerebrospinal fluid. The oxygenation mechanism 312 supplies the oxygenated cerebrospinal fluid as a highly oxygenated solution to the first flow path switching unit 333 through the first tube 41. As the oxygenation mechanism 312 in this embodiment, a hollow fiber type artificial lung for adding oxygen to blood can be used.

[0079] The first flow path switching unit 333 is provided at the connection between the first tube 41, the second tube 42, and the third tube 43, and is capable of switching between a flow path connecting the first tube 41 and the second tube 42 and a flow path connecting the second tube 42 and the third tube 43. Specifically, the second drive unit 24 controls the operation of the first flow path switching unit 333 based on a control signal transmitted from the control unit 21, and switches between the flow path connecting the first tube 41 and the second tube 42 and the flow path connecting the second tube 42 and the third tube 43.

[0080] The first flow path switching unit 333 is connected to the first syringe 331 via the second tube 42. The first piston 332 is capable of sliding and reciprocating within the first syringe 331. Specifically, the first drive unit 23 controls the operation of the first piston 332 based on a control signal transmitted from the control unit 21, and causes the first piston 332 to reciprocate within the first syringe 331. When the first piston 332 moves in a direction to be removed from the first syringe 331 in a state in which the first flow path switching unit 333 connects the first tube 41 and the second tube 42, the first syringe 331 stores the liquid supplied from the oxygenation mechanism 312 through the first tube 41 and the second tube 42. On the other hand, when the first flow path switching unit 333 connects the second tube 42 and the third tube 43, when the first piston 332 moves in the direction of being inserted into the first syringe 331, the first piston 332 supplies the liquid stored in the first syringe 331 to the injection catheter 52 through the second tube 42 and the third tube 43.

[0081] In this way, the first syringe 331 temporarily stores the liquid to be injected into the body. The first piston 332 is connected to the first syringe 331 and is also connected to the injection catheter 52 via the second tube 42 and the third tube 43, and supplies the liquid to the first syringe 331 and supplies the liquid stored in the first syringe 331 to the injection catheter 52.

[0082] As shown in FIG. 17, the reservoir 311 is connected to the second flow path switching unit 336 via the sixth pipe 46. The reservoir 311 is also connected to the oxygenation mechanism 312 via the seventh pipe 47. The reservoir 311 temporarily stores the cerebrospinal fluid supplied through the sixth pipe 46. The reservoir 311 then supplies the stored cerebrospinal fluid to the oxygenation mechanism 312 through the seventh pipe 47. The reservoir 311 has a structure in which the inside and the outside are mutually connected, and can release gas contained in the stored cerebrospinal fluid to the outside. In other words, the reservoir 311 functions as an air trap.

[0083] The second flow path switching unit 336 is provided at the connection between the fourth tube 44, the fifth tube 45, and the sixth tube 46, and is capable of switching between a flow path connecting the fourth tube 44 and the fifth tube 45 and a flow path connecting the fifth tube 45 and the sixth tube 46. Specifically, the third drive unit 25 controls the operation of the second flow path switching unit 336 based on a control signal transmitted from the control unit 21, and switches between the flow path connecting the fourth tube 44 and the fifth tube 45 and the flow path connecting the fifth tube 45 and the sixth tube 46.

[0084] The second flow path switching unit 336 is connected to the second syringe 334 via the fifth tube 45. The second piston 335 can slide and reciprocate within the second syringe 334. Specifically, the first driving unit 23 controls the operation of the second piston 335 based on a control signal transmitted from the control unit 21, and causes the second piston 335 to reciprocate within the second syringe 334. That is, as shown in FIG. 17, the first piston 332 and the second piston 335 are connected to each other, and in a connected state, they reciprocate by receiving a driving force from the first driving unit 23. When the second flow path switching unit 336 connects the fourth tube 44 and the fifth tube 45, and the second piston 335 moves in a direction to be removed from the second syringe 334, the second syringe 334 stores the liquid (i.e., cerebrospinal fluid) discharged from inside the body to outside the body through the fourth tube 44 and the fifth tube 45. On the other hand, when the second flow path switching unit 336 connects the fifth tube 45 and the sixth tube 46, when the second piston 335 moves in the direction of being inserted into the second syringe 334, the second piston 335 supplies the liquid stored in the second syringe 334 to the reservoir 311 through the fifth tube 45 and the sixth tube 46.

[0085] In this way, the second piston 335 is connected to the second syringe 334 and is also connected to the discharge catheter 51 via the fourth tube 44 and the fifth tube 45, supplying liquid to the second syringe 334 and supplying the liquid stored in the second syringe 334 to the reservoir 311.

[0086] The first syringe 331 and the second syringe 334 are formed to have the same shape and capacity. As described above, the first piston 332 and the second piston 335 are connected to each other, and in the connected state, they reciprocate by receiving the driving force of the first driving unit 23. As a result, the volume of liquid injected into the body is always equal to the volume of liquid discharged from the body.

[0087] 18 and 19 are schematic diagrams illustrating the operation of the liquid circulation system according to this embodiment. The operation of the liquid circulation system 3 described with reference to FIGS. 18 and 19 is based on the first control described above with reference to FIGS. For ease of explanation, the control unit 21, the first driving unit 23, the second driving unit 24, and the third driving unit 25 are omitted in Figures 18 and 19. Also, the operation described below will be explained assuming that the tubes and reservoirs in the circuit, the pumps (syringes), and the oxygenation mechanism are started from a primed state in which they are filled with artificial cerebrospinal fluid such as lactated Ringer's solution.

[0088] 18, in a first step, the control unit 21 transmits a control signal to the second driving unit 24 to control the operation of the first flow path switching unit 333, and connects the first tube 41 and the second tube 42. The control unit 21 also transmits a control signal to the third driving unit 25 to control the operation of the second flow path switching unit 336, and connects the fifth tube 45 and the sixth tube 46. In this state, the control unit 21 transmits a control signal to the first driving unit 23 to move the first piston 332 in the direction in which the first syringe 331 is removed, and move the second piston 335 in the direction in which the second syringe 334 is inserted, as indicated by the arrow A31 in FIG.

[0089] Then, as shown by an arrow A32 in Fig. 18, the liquid 91 (i.e., the highly oxygenated solution) produced in the oxygenation mechanism 312 is supplied to and stored in the first syringe 331 through the first tube 41 and the second tube 42. Also, as shown by an arrow A33 in Fig. 18, the cerebrospinal fluid 92 (see Fig. 19) stored in the second syringe 334 is supplied to and stored in the reservoir 311 through the fifth tube 45 and the sixth tube 46. Furthermore, as shown by an arrow A34 in Fig. 18, the cerebrospinal fluid 92 stored in the reservoir 311 is supplied to the oxygenation mechanism 312 through the seventh tube 47.

[0090] 19, in a second step, the control unit 21 transmits a control signal to the second drive unit 24 to control the operation of the first flow path switching unit 333, and connects the second tube 42 and the third tube 43. The control unit 21 also transmits a control signal to the third drive unit 25 to control the operation of the second flow path switching unit 336, and connects the fourth tube 44 and the fifth tube 45. In this state, the control unit 21 transmits a control signal to the first drive unit 23 to move the first piston 332 in the insertion direction of the first syringe 331, and move the second piston 335 in the removal direction of the second syringe 334, as indicated by the arrow A35 in FIG.

[0091] Then, as shown by an arrow A36 in FIG. 19, the liquid 91 (i.e., the highly oxygenated solution) stored in the first syringe 331 is supplied to the injection catheter 52 through the second tube 42 and the third tube 43. Then, as shown by an arrow A13 in FIG. 19, for example, the liquid 91 is injected into the body from the injection port 521 of the injection catheter 52. Meanwhile, as shown by an arrow A11 in FIG. 19, for example, the cerebrospinal fluid 92 in the body is sucked into the outlet 511 of the drainage catheter 51. Then, as shown by an arrow A37 in FIG. 19, the cerebrospinal fluid 92 is sucked into the second syringe 334 through the fourth tube 44 and the fifth tube 45 and stored therein.

[0092] 20 to 23 are schematic diagrams illustrating other operations of the liquid circulation system according to this embodiment. The operation of the liquid circulation system 3 described with reference to FIGS. 20 to 23 is based on the second control described above with reference to FIGS. For ease of explanation, the control unit 21, the first driving unit 23, the second driving unit 24, and the third driving unit 25 are omitted in FIGS.

[0093] 20, in a first step, the control unit 21 transmits a control signal to the second driving unit 24 to control the operation of the first flow path switching unit 333, and connects the first tube 41 and the second tube 42. The control unit 21 also transmits a control signal to the third driving unit 25 to control the operation of the second flow path switching unit 336, and connects the fourth tube 44 and the fifth tube 45. In this state, the control unit 21 transmits a control signal to the first driving unit 23 to move the first piston 332 in the insertion direction of the first syringe 331, and move the second piston 335 in the removal direction of the second syringe 334, as indicated by the arrow A41 in FIG.

[0094] Then, as indicated by an arrow A42 in Fig. 20, the liquid 91 (i.e., the highly oxygenated solution) stored in the first syringe 331 is returned to the oxygenation mechanism 312 through the first tube 41 and the second tube 42. Meanwhile, as indicated by an arrow A11 in Fig. 20, for example, cerebrospinal fluid 92 in the body is sucked into the outlet 511 of the drainage catheter 51. Then, as indicated by an arrow A43 in Fig. 20, the cerebrospinal fluid 92 is sucked into the second syringe 334 through the fourth tube 44 and the fifth tube 45 and stored therein.

[0095] 21, in a second step, the control unit 21 transmits a control signal to the second driving unit 24 to control the operation of the first flow path switching unit 333, thereby connecting the first tube 41 and the second tube 42 (i.e., maintaining the connection state). The control unit 21 also transmits a control signal to the third driving unit 25 to control the operation of the second flow path switching unit 336, thereby connecting the fifth tube 45 and the sixth tube 46. In this state, the control unit 21 transmits a control signal to the first driving unit 23 to move the first piston 332 in the direction in which the first syringe 331 is removed, and move the second piston 335 in the direction in which the second syringe 334 is inserted, as indicated by the arrow A44 in FIG.

[0096] Then, as shown by an arrow A45 in Fig. 21, the liquid 91 (i.e., the highly oxygenated solution) produced in the oxygenation mechanism 312 is supplied to and stored in the first syringe 331 through the first tube 41 and the second tube 42. Also, as shown by an arrow A46 in Fig. 21, the cerebrospinal fluid 92 stored in the second syringe 334 is supplied to and stored in the reservoir 311 through the fifth tube 45 and the sixth tube 46. Furthermore, as shown by an arrow A47 in Fig. 21, the cerebrospinal fluid 92 stored in the reservoir 311 is supplied to the oxygenation mechanism 312 through the seventh tube 47.

[0097] 22, in a third step, the control unit 21 transmits a control signal to the second driving unit 24 to control the operation of the first flow path switching unit 333, and connects the second tube 42 and the third tube 43. The control unit 21 also transmits a control signal to the third driving unit 25 to control the operation of the second flow path switching unit 336, and connects the fifth tube 45 and the sixth tube 46 (i.e., maintains the connection state). In this state, the control unit 21 transmits a control signal to the first driving unit 23 to move the first piston 332 in the insertion direction of the first syringe 331, and move the second piston 335 in the removal direction of the second syringe 334, as indicated by the arrow A48 in FIG. 22.

[0098] Then, as indicated by an arrow A49 in Fig. 22, the liquid 91 (i.e., the highly oxygenated solution) stored in the first syringe 331 is supplied to the injection catheter 52 through the second tube 42 and the third tube 43. Then, as indicated by an arrow A13 in Fig. 22, for example, the liquid 91 is injected into the body from the injection port 521 of the injection catheter 52. Meanwhile, as indicated by an arrow A51 in Fig. 22, the cerebrospinal fluid 92 stored in the reservoir 311 is returned to the second syringe 334 through the fifth tube 45 and the sixth tube 46.

[0099] 23, in a fourth step, the control unit 21 transmits a control signal to the second driving unit 24 to control the operation of the first flow path switching unit 333, and connects the first tube 41 and the second tube 42. The control unit 21 also transmits a control signal to the third driving unit 25 to control the operation of the second flow path switching unit 336, and connects the fifth tube 45 and the sixth tube 46 (i.e., maintains the connection state). In this state, the control unit 21 transmits a control signal to the first driving unit 23 to move the first piston 332 in the direction in which the first syringe 331 is removed, and move the second piston 335 in the direction in which the second syringe 334 is inserted, as indicated by the arrow A52 in FIG. 23.

[0100] Then, as shown by an arrow A53 in Fig. 23, the liquid 91 (i.e., the highly oxygenated solution) produced in the oxygenation mechanism 312 is supplied to and stored in the first syringe 331 through the first tube 41 and the second tube 42. Also, as shown by an arrow A54 in Fig. 23, the cerebrospinal fluid 92 stored in the second syringe 334 is supplied to and stored in the reservoir 311 through the fifth tube 45 and the sixth tube 46. Furthermore, as shown by an arrow A55 in Fig. 23, the cerebrospinal fluid 92 stored in the reservoir 311 is supplied to the oxygenation mechanism 312 through the seventh tube 47.

[0101] According to the liquid circulation system 3 of this embodiment, the circuit for circulating the liquid is divided into a circuit including the injection catheter 52 and the discharge catheter 51 (i.e., the biological circuit section 32), and the system circuit section 31 connected to the injection catheter 52 and the discharge catheter 51. In addition, the first piston 332 that supplies the liquid to the injection catheter 52 and the second piston 335 that supplies the liquid to the system circuit section 31 function as a liquid sending section shared by the biological circuit section 32 and the system circuit section 31. In addition, the first flow path switching section 333 and the second flow path switching section 336 can switch the flow path through which the liquid flows. With this configuration of the liquid circulation system 3, the system circuit section 31 can respond to an increase in the total volume of the liquid caused by the cavitation phenomenon and a decrease in the total volume of the liquid caused by evaporation while maintaining the condition on the biological side, and can suppress an increase or decrease in the total volume of the liquid. This can suppress fluctuations in intracranial pressure.

[0102] In addition, the first piston 332 and the second piston 335 operate in conjunction with each other and function as one liquid delivery unit shared by the biological circuit unit 32 and the system circuit unit 31. The first syringe 331 and the second syringe 334 are formed with the same shape and capacity. Therefore, the volume of liquid injected into the body is always equal to the volume of liquid discharged from the body. Such a fixed-capacity pump does not fluctuate the amount of liquid injected and discharged in one cycle, and can reliably make the injected amount and the discharged amount the same compared to a variable-capacity pump. Therefore, the amount of cerebrospinal fluid in the body can be more reliably kept within a constant range. This makes it possible to more reliably suppress fluctuations in intracranial pressure.

[0103] Furthermore, when the liquid injected into the body is a highly oxygenated solution, the highly oxygenated solution can be efficiently delivered to the treatment area of ​​the brain while suppressing fluctuations in intracranial pressure.

[0104] The above describes the embodiments of the present invention. However, the present invention is not limited to the above embodiments, and various modifications can be made without departing from the scope of the claims. The configurations of the above embodiments can be partially omitted or arbitrarily combined in a manner different from the above. [Explanation of symbols]

[0105] 2: medical system, 3: liquid circulation system, 5: medical device, 21: control unit, 22: pump, 23: first drive unit, 24: second drive unit, 25: third drive unit, 31: system circuit unit, 32: biological circuit unit, 33: pump unit, 41: first tube, 42: second tube, 43: third tube, 44: fourth tube, 45: fifth tube, 46: sixth tube, 47: seventh tube, 48: eighth tube, 51: drainage catheter, 52: infusion catheter, 53: space, 55: tube, 56: tank, 91: liquid, 92: cerebrospinal fluid, 211: first period, 212: second period, 213: third period, 214: fourth period, 311: reservoir, 312: oxygenation mechanism, 313: oxygen supply source, 331: first syringe, 332: first piston, 333: first flow path switching unit, 334: second syringe, 335: second piston, 336: second flow path switching unit, 511: outlet, 513: inner cavity, 521: inlet, 523: inner cavity, 911: colored water

Claims

1. A medical system for injecting a liquid into a body cavity in which cerebrospinal fluid of a subject is present, and discharging the cerebrospinal fluid present in the body cavity from the body cavity, comprising: a first period during which the cerebrospinal fluid is drained from the body cavity while the fluid is being injected into the body cavity; a second period during which the fluid is not injected into the body cavity and the cerebrospinal fluid is not drained from the body cavity; and a control unit that sets a first period and a second period and executes control to alternately repeat the first period and the second period.

2. 2. The medical system of claim 1, wherein the amount of fluid infused during the first period is substantially the same as the amount of cerebrospinal fluid drained during the first period.

3. 2. The medical system of claim 1, wherein a period from the start of the first period to the end of the second period is substantially constant.

4. The medical system of claim 1 , wherein the second period of time is greater than or equal to 15 seconds.

5. The control is a first control, The control unit is a third period during which the fluid is injected into the body cavity and the cerebrospinal fluid is not drained from the body cavity; a fourth period during which the liquid is not injected into the body cavity and the cerebrospinal fluid is drained from the body cavity; the third period and the fourth period are alternately repeated, and the amount of the liquid injected in the third period is set to be substantially the same as the amount of the cerebrospinal fluid discharged in the fourth period, and a second control is further executable, wherein either one of the first control or the second control is selected and executed.

6. an injection catheter for injecting the liquid into the body cavity; a drainage catheter for draining the cerebrospinal fluid from the body cavity; Further equipped with 2. The medical system of claim 1, wherein the distance between the tip of the infusion catheter and the tip of the drainage catheter is less than 30 centimeters when execution of the control begins.

7. A liquid circulation system that circulates a liquid by injecting the liquid into a body and discharging the liquid out of the body, an infusion catheter for infusing the fluid into the body; a drainage catheter for draining the fluid from within the body to outside the body; system circuitry connected to the infusion catheter and the drainage catheter; an infusion liquid storage section that stores the liquid supplied from the system circuit section and to be injected into the body; A drainage liquid storage section that stores the liquid drained from inside the body to outside the body; a first fluid delivery unit connected to the infusion fluid storage unit and the injection catheter, for supplying the fluid to the infusion fluid storage unit and supplying the fluid stored in the infusion fluid storage unit to the injection catheter; a second fluid delivery unit connected to the drainage fluid storage unit and the drainage catheter, for supplying the fluid to the drainage fluid storage unit and supplying the fluid stored in the drainage fluid storage unit to the system circuit unit; a first flow path switching unit that is provided downstream of the infusion liquid storage unit and is capable of switching between a flow path in which the system circuit unit is connected to the infusion liquid storage unit and a flow path in which the infusion liquid storage unit is connected to the injection catheter; a second flow path switching unit that is provided upstream of the drainage fluid storage unit and is capable of switching between a flow path that connects the drainage catheter to the drainage fluid storage unit and a flow path that connects the drainage fluid storage unit to the system circuit unit; A liquid circulation system comprising:

8. The liquid circulation system described in claim 7, characterized in that the first liquid delivery unit and the second liquid delivery unit operate in conjunction with each other, so that the volume of liquid injected into the body is always equal to the volume of liquid discharged outside the body.

9. Further comprising a piston drive unit, the injection liquid storage portion is a first syringe that stores the liquid, the discharged liquid storage portion is a second syringe that stores the liquid, the first liquid delivery section is a first piston that is slidable and reciprocable within the first syringe, the second liquid delivery unit is a second piston that is slidable and reciprocable within the second syringe, 8. The liquid circulation system according to claim 7, wherein the first piston and the second piston are connected to each other and reciprocate in the connected state by the piston drive portion.

10. The liquid circulation system of claim 9, characterized in that the first syringe and the second syringe are formed to have the same shape and capacity, so that the volume of the liquid injected into the body is always equal to the volume of the liquid discharged from the body.

11. 8. The liquid circulation system according to claim 7, wherein the system circuit unit has an oxygen supply device that supplies oxygen to the liquid discharged from the body.

Citation Information

Patent Citations

  • Catheter and catheter system

    WO2021192539A1